Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Applying to Winship Cancer Institute · Atlanta, Georgia
Answer a few short questions to share with the research team.